Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments.

Lassau N, Chami L, Chebil M, Benatsou B, Bidault S, Girard E, Abboud G, Roche A.

Discov Med. 2011 Jan;11(56):18-24.

2.

Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment.

Lassau N, Chebil M, Chami L, Bidault S, Girard E, Roche A.

Target Oncol. 2010 Mar;5(1):53-8. doi: 10.1007/s11523-010-0136-7. Epub 2010 Apr 9. Review.

PMID:
20379790
3.
4.

Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study.

Lassau N, Chapotot L, Benatsou B, Vilgrain V, Kind M, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Uzan-Augui J, Koscielny S.

Invest Radiol. 2012 Dec;47(12):711-6. doi: 10.1097/RLI.0b013e31826dc255.

PMID:
23095862
5.

Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.

Lassau N, Chami L, Koscielny S, Chebil M, Massard C, Benatsou B, Bidault S, Cioffi A, Blay JY, Le Cesne A.

Invest New Drugs. 2012 Apr;30(2):765-71. doi: 10.1007/s10637-010-9592-2. Epub 2010 Dec 7.

PMID:
21136137
6.

[Imaging and angiogenesis: DCE-US (dynamic contrast enhanced-ultrasonography)].

Lassau N, Roche A.

Bull Cancer. 2007 Jul;94 Spec No:S247-53. Review. French.

PMID:
17846011
7.

Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.

Egger C, Goertz RS, Strobel D, Lell M, Neurath MF, Knieling F, Scharf M.

Ultraschall Med. 2012 Dec;33(6):587-92. doi: 10.1055/s-0032-1325545. Epub 2012 Nov 15.

PMID:
23154871
8.

Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.

Wang H, Lutz AM, Hristov D, Tian L, Willmann JK.

Radiology. 2017 Feb;282(2):443-452. doi: 10.1148/radiol.2016160032. Epub 2016 Aug 4.

9.

Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography.

Lassau N, Koscielny S, Albiges L, Chami L, Benatsou B, Chebil M, Roche A, Escudier BJ.

Clin Cancer Res. 2010 Feb 15;16(4):1216-25. doi: 10.1158/1078-0432.CCR-09-2175. Epub 2010 Feb 9.

10.

Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.

Pitre-Champagnat S, Leguerney I, Bosq J, Peronneau P, Kiessling F, Calmels L, Coulot J, Lassau N.

Invest Radiol. 2015 Apr;50(4):212-7. doi: 10.1097/RLI.0000000000000101.

PMID:
25275834
11.

DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker.

Chen BB, Shih TT.

World J Gastroenterol. 2014 Mar 28;20(12):3125-34. doi: 10.3748/wjg.v20.i12.3125. Review.

12.

Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.

Lassau N, Bonastre J, Kind M, Vilgrain V, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe-Devilliers C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Feutray S, Uzan-Augui J, Coiffier B, Benastou B, Koscielny S.

Invest Radiol. 2014 Dec;49(12):794-800. doi: 10.1097/RLI.0000000000000085.

13.

Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.

Lassau N, Koscielny S, Chami L, Chebil M, Benatsou B, Roche A, Ducreux M, Malka D, Boige V.

Radiology. 2011 Jan;258(1):291-300. doi: 10.1148/radiol.10091870. Epub 2010 Oct 27.

PMID:
20980447
14.

Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results.

Frampas E, Lassau N, Zappa M, Vullierme MP, Koscielny S, Vilgrain V.

Eur J Radiol. 2013 May;82(5):e205-11. doi: 10.1016/j.ejrad.2012.12.004. Epub 2012 Dec 28.

PMID:
23273822
15.

Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.

Kim J, Kim JH, Yoon SH, Choi WS, Kim YJ, Han JK, Choi BI.

Ultrasound Med Biol. 2015 Dec;41(12):3131-9. doi: 10.1016/j.ultrasmedbio.2015.07.031. Epub 2015 Sep 11.

PMID:
26365926
16.

Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials.

Leen E, Averkiou M, Arditi M, Burns P, Bokor D, Gauthier T, Kono Y, Lucidarme O.

Eur Radiol. 2012 Jul;22(7):1442-50. doi: 10.1007/s00330-011-2373-2.

PMID:
22302501
17.

An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.

Dietrich CF, Averkiou MA, Correas JM, Lassau N, Leen E, Piscaglia F.

Ultraschall Med. 2012 Aug;33(4):344-51. Epub 2012 Jul 27.

PMID:
22843433
18.

Ultrasound imaging of breast tumor perfusion and neovascular morphology.

Hoyt K, Umphrey H, Lockhart M, Robbin M, Forero-Torres A.

Ultrasound Med Biol. 2015 Sep;41(9):2292-302. doi: 10.1016/j.ultrasmedbio.2015.04.016. Epub 2015 Jun 24.

19.

Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US.

Sugimoto K, Moriyasu F, Saito K, Rognin N, Kamiyama N, Furuichi Y, Imai Y.

Liver Int. 2013 Apr;33(4):605-15. doi: 10.1111/liv.12098. Epub 2013 Jan 11.

PMID:
23305331
20.

Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy.

Williams R, Hudson JM, Lloyd BA, Sureshkumar AR, Lueck G, Milot L, Atri M, Bjarnason GA, Burns PN.

Radiology. 2011 Aug;260(2):581-90. doi: 10.1148/radiol.11101893. Epub 2011 May 9.

PMID:
21555352

Supplemental Content

Support Center